Vrt 043198

Vrt 043198

SCHEMBL20099210

CC(C)(C)C(NC(=O)c1ccc(N)c(Cl)c1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C=O)CC(=O)O

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 8/20 0.81
CASP4 P49662 2/20 0.81
CASP5 P51878 2/20 0.81
CASP7 P55210 2/20 0.81
CASP9 P55211 2/20 0.81
CASP8 Q14790 2/20 0.81
CASP10 Q92851 2/20 0.81
ELANE P08246 2/20 0.44
TAAR1 Q96RJ0 1/20 0.43
IL1B P01584 2/20 0.41
CASP3 P42574 1/20 0.40
CASP2 P42575 1/20 0.40
ITGB1 P05556 1/20 0.39
ITGA4 P13612 1/20 0.39
STAT6 P42226 4/20 0.38
F2 P00734 3/20 0.38
F10 P00742 2/20 0.38
PRSS1 P07477 2/20 0.38
PRSS2 P07478 2/20 0.38
PRSS3 P35030 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vrt 043198 SCHEMBL13928446 1.00 CASP1 (0.81) CASP1CASP4CASP5CASP7CASP9
Vrt 043198 SCHEMBL3470537 1.00 CASP1 (0.81) CASP1CASP4CASP5CASP7CASP9
Vrt 043198 SCHEMBL8279029 1.00 CASP1 (0.81) CASP1CASP4CASP5CASP7CASP9
Vrt 043198 SCHEMBL30278640 1.00 CASP1 (0.81) CASP1CASP4CASP5CASP7CASP9
Vrt 043198 SCHEMBL17969594 1.00 CASP1 (0.81) CASP1CASP4CASP5CASP7CASP9
Vrt 043198 SCHEMBL20298437 1.00 CASP1 (0.81) CASP1CASP4CASP5CASP7CASP9
SCHEMBL16883406 0.94 CASP1 (0.71) CASP1CASP4CASP5CASP7CASP9
SCHEMBL13742740 0.94 CASP1 (0.71) CASP1CASP4CASP5CASP7CASP9
SCHEMBL3469978 0.90 CASP1 (0.66) CASP1CASP4CASP5CASP7CASP9
SCHEMBL15459247 0.90 CASP1 (1.00) CASP1CASP4CASP5CASP7CASP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9956260-B1 Treatment of HIV-1 infection and AIDS THE J. DAVID GLADSTONE INSTITUTES (US) 2018-05-01 US disclosed